Back to results
US 2026/0272953 A1Published application
Cannabinoid formulations
AssigneeDsm IP Assets B.V.
InventorsAhmed BESHEER, Elger FUNDA, Thomas LINDEMANN, Christian SCHAEFER, Christiane SCHWEIGGERT, Thomas ZWICK
Life of this patent
Estimating the term…
Abstract
The present invention relates to a new formulation comprising a high amount of at least one cannabinoid, wherein the cannabinoid is in a non-crystalline form.
Claims15
A solid formulation comprising
- (i) 5-85 wt-%, based on the total weight of the solid formulation, of at least one cannabinoid, and
- (ii) 2 to 25 wt-%, based on the total weight of the solid formulation, of at least one MCT oil, and
- (iii) 1 to 50 wt-%, based on the total weight of the solid formulation, of at least one emulsifier, and
- (iv) optionally up to 40 wt-%, based on the total weight of the solid formulation, of at least one auxiliary agent, and
- (v) less than 5 wt-%, based on the total weight of the solid formulation, of water,
- wherein at least 50 wt-%, based on the total weight of the cannabinoid, of the at least one cannabinoid is in a non-crystalline form and
- the ratio of the at least one cannabinoid to MCT oil is 2:1 to 4:1.
4 more elements
Use of a MCT oil to enhance the bioavailability of at least one cannabinoid, preferably of cannabidiol, most preferably in the form of a solid formulation according to anyone of the embodiments 1 to 12.
Dependencies are inferred from the claim text.